Options
Features
Unusual Option Volume
Implied Volatility Rankings
Option Volumes
Snapshot
Options Broad View
Put Protection
Buy Writes Search
For Premium Users
Tools
Implied Volatility Movers
Zero DTE Option Straddles
Featured Trade Ideas
Order Flow Sentiment
Overview
Top Bullish
Top Bearish
Open Interest
OI Analysis
Catalyst Events
Biotech Stock Catalysts
Straddle & Wing Backtest
Volatility Compare
Straddle Compare
Large Delta Volume Trades
Stocks
Non-Regular Hours
Premarket Trading
After Hours Trading
Opening Auction
Closing Auction
Features
Market Movers
S&P 500 Volume Burst Trades
52-Week Highs & Lows
Stock Order Imbalance
Unusual Stock Volume
Morning Report
Company Events
Market Action Lists
Top Gainers on High Volume
Top Losers on High Volume
Outperforming Stocks
Gap Up and Go
Gap Down and Go
Dividends
Calendar
REITs
MLPs
Closed End Funds
For Premium Users
Reports
Order Imbalance History
New Listings
Closed End Funds
Splits
Threshold List
Market Insights
Performance By Industry
Fast Cash Burn Report
PDUFA Dates
Mergers & Acquisitions
Screeners
Seasonality
Event-Driven Screener
Big Money Stock Flow
Insider Trades Screener
Volume Burst Screener
Tools
Price Action Analysis
Dividends
Announcements
Future Ex-Dates
Dividend Increases
Best Dividends
Dividend Comparisons
Screeners
Features
Market Alerts, Insights & Trade Ideas
Stocks
Options By Expiration
Option Block Trades
ETFs
For Premium Users
Vertical Spreads
Bull Call Spreads [Debit]
Bull Put Spreads [Credit]
Bear Call Spreads [Credit]
Bear Put Spreads [Debit]
Multi-Leg Trades
Multi-Leg Trade Screener
Index Options Multi-Leg
Single-Leg Strategies
Covered Calls
Naked Puts
Long Calls
Long Puts
Calendar Spreads
Debit Calendar Call
Debit Calendar Put
Butterfly Screeners
Call Butterflies [Short ATM, Long OTM]
Call Butterflies [Long ATM, Short OTM]
Put Butterflies [Short ATM, Long OTM]
Put Butterflies [Long ATM, Short OTM]
Iron Butterflies [Short ATM, Long OTM]
Iron Butterflies [Long ATM, Short OTM]
Condor Screeners
Iron Condors [Long Inner, Short Outer]
Iron Condors [Short Inner, Long Outer]
Volatility
Straddles [At-The-Money]
Conversion/Reversal
Synthetic Long Stock Discounts
Earnings
Features
Calendar
For Premium Users
Tools
Future Dates
Earnings Stock Pattern Screener
Earnings Option Strategy Screener
Today's Opportunities
Company Earnings Guidance
Upcoming Earnings Analysis
Summary and Tables
Implied Move Charts
Earnings Insights
Straddle Performance
Earnings Stock Moves
News
Features
Latest Press Releases
Original Articles
Economic Calendar
For Premium Users
Tools
Historical News Scanner
My Account
Account Tools
My Account
My Watchlists
My E-mail Alerts
My Subscriptions
Login
Helpful Links
Reviews
Register Free
Videos
Help
Video Guide
Site Features
Glossary
Financial Concepts
Options Basics
Options Strategies
Have a Question?
Services
Newsletters (Free)
Starter (Free)
Total Access
Help AI
Free Trial
Login
SPRO
MENU
SPRO
MENU
❌
CLOSE
STOCK INFO
Summary
Chart
Dividends
Price Action
Historical Data
Insider Trades
FUNDAMENTALS
Summary
Peer Comps
Fair Value
Payback Period
Income Statement
Cash Flow Statement
Balance Sheet
EARNINGS
Interactive Charts
Release Dates
Implied Moves And IV Crush
Earnings Moves
Option Strategies
EPS Estimate vs. Actual
Today's Trade Ideas
Post Earnings Drift
OPTIONS
Option Chain
Trade Ideas
Order Sentiment
Time and Sales
Single Leg Dashboard
Multi Leg Trades
Strategy Benchmarks
Activity
Open Interest
Historical Chart
Strategy Payout
VOLATILITY
Implied Volatility
Skew
Seasonality
Stock Volatility
Risk Premium
Implied Moves
TOOLS
Seasonality
Events
ATM Straddle
Intraday Returns
COMPANY INFO
About
Similar Stocks
NEWS
Headline News (0)
Press Releases
Posts
LINKS
Company Website
SEC Filings
SPRO Latest Press Releases
-- March 26, 2026 --
Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
Globe Newswire 4:05 PM
-- March 18, 2026 --
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Globe Newswire 4:05 PM
-- December 19, 2025 --
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
Globe Newswire 8:00 AM
-- November 28, 2025 --
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes
Questions? Feedback?
powered by
Olark live chat software
